ES2079687T3 - Composicion topica. - Google Patents

Composicion topica.

Info

Publication number
ES2079687T3
ES2079687T3 ES91920206T ES91920206T ES2079687T3 ES 2079687 T3 ES2079687 T3 ES 2079687T3 ES 91920206 T ES91920206 T ES 91920206T ES 91920206 T ES91920206 T ES 91920206T ES 2079687 T3 ES2079687 T3 ES 2079687T3
Authority
ES
Spain
Prior art keywords
liquid phases
topic composition
application
topic
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91920206T
Other languages
English (en)
Inventor
Adrian Francis Davis
Jennifer Jane Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of ES2079687T3 publication Critical patent/ES2079687T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS DE DOS COMPONENTES PARA SU APLICACION TOPICA AL CUERPO HUMANO O ANIMAL Y PENSADOS PARA QUE SE MEZCLEN ENTRE SI EN EL MOMENTO O INMEDIATAMENTE ANTES DE SU APLICACION, QUE COMPRENDE DOS FASES LIQUIDAS QUE TIENEN DISTINTAS LIPOFILICIDADES Y UN FARMACO DISUELTO EN AL MENOS UNA DE LAS FASES LIQUIDAS.
ES91920206T 1990-11-27 1991-11-21 Composicion topica. Expired - Lifetime ES2079687T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909025711A GB9025711D0 (en) 1990-11-27 1990-11-27 Topical composition

Publications (1)

Publication Number Publication Date
ES2079687T3 true ES2079687T3 (es) 1996-01-16

Family

ID=10686018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91920206T Expired - Lifetime ES2079687T3 (es) 1990-11-27 1991-11-21 Composicion topica.

Country Status (18)

Country Link
EP (1) EP0559682B1 (es)
JP (1) JPH06502856A (es)
KR (1) KR100218652B1 (es)
AT (1) ATE128862T1 (es)
AU (1) AU661283B2 (es)
CA (1) CA2096963C (es)
DE (1) DE69113811T2 (es)
DK (1) DK0559682T3 (es)
ES (1) ES2079687T3 (es)
GB (1) GB9025711D0 (es)
GR (1) GR3018613T3 (es)
IE (1) IE68953B1 (es)
MY (1) MY108692A (es)
NZ (1) NZ240707A (es)
PT (1) PT99608B (es)
SA (1) SA92120308B1 (es)
WO (1) WO1992009266A1 (es)
ZA (1) ZA919289B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125712D0 (en) * 1991-12-03 1992-01-29 Smithkline Beecham Plc Skin care composition
GB9207988D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Topical composition
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US6019988A (en) * 1996-11-18 2000-02-01 Bristol-Myers Squibb Company Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage
FR2771634B1 (fr) * 1997-12-02 2000-04-28 Jean Pierre Benoit Produit d'hygiene capillaire et/ou corporelle pour les hommes et les animaux et procede pour sa fabrication
US6649174B2 (en) 1998-05-07 2003-11-18 E-L Management Corp. Dual phase cosmetic composition
US6524623B1 (en) * 1999-11-12 2003-02-25 Milton Hodosh Therapeutic compositions and methods of use thereof
DE10235422A1 (de) * 2002-08-02 2004-02-12 Beiersdorf Ag Kosmetische Zubereitungen mit zwei Phasen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319540D0 (en) * 1983-07-20 1983-08-24 Bovril Ltd Amine removal
GB8629639D0 (en) * 1986-12-11 1987-01-21 Beecham Group Plc Composition & method
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition

Also Published As

Publication number Publication date
AU8929591A (en) 1992-06-25
IE68953B1 (en) 1996-07-24
IE914090A1 (en) 1992-06-03
SA92120308B1 (ar) 2005-06-15
DE69113811T2 (de) 1996-04-11
DE69113811D1 (de) 1995-11-16
CA2096963A1 (en) 1992-05-28
ZA919289B (en) 1992-10-28
GR3018613T3 (en) 1996-04-30
KR930702958A (ko) 1993-11-29
JPH06502856A (ja) 1994-03-31
DK0559682T3 (da) 1995-12-04
NZ240707A (en) 1994-02-25
PT99608A (pt) 1992-11-30
PT99608B (pt) 1999-05-31
KR100218652B1 (ko) 1999-09-01
MY108692A (en) 1996-10-31
HK1006279A1 (en) 1999-02-19
ATE128862T1 (de) 1995-10-15
GB9025711D0 (en) 1991-01-09
EP0559682B1 (en) 1995-10-11
CA2096963C (en) 2002-04-30
EP0559682A1 (en) 1993-09-15
WO1992009266A1 (en) 1992-06-11
AU661283B2 (en) 1995-07-20

Similar Documents

Publication Publication Date Title
FI883055A7 (fi) Deodoroiva ja antimikrobinen koostumus käytettäväksi kosmeettisissa tai paikallisesti käytettävissä valmisteissa.
BG103552A (bg) Терапевтични средства
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
KR900701252A (ko) 코로 투약하는 벤조디아제핀 최면제
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
DE69301356D1 (de) Übersättigte topische zusammensetzungen
FI952920L (fi) 7-halogeeni- ja 7beta,8beta-metano-taksolit, niiden antineoplastinen käyttö ja niitä sisältävät farmaseuttiset koostumukset
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DK0439042T3 (da) Anvendelse af farmaceutiske og kosmetiske præparater med blandingsmiceller
LV10183A (lv) Perorala kompozicija zarnu iekaisuma slimibu arstesanai
SE8702642D0 (sv) Lokalt anvendbara, pharmaceutiska beredningar
PT999843E (pt) Composicoes farmaceuticas contendo vitamina d e calcio, sua preparacao e uso terapeutico
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
EE04493B1 (et) Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks
ES2079687T3 (es) Composicion topica.
KR940018087A (ko) 진통제 및 소염제로서의 6-클로로-5-플루오로-3-(2-테노일)-2-옥신돌-ⅰ-카복스아미드
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
ITMI942663A0 (it) Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono
AR011437A1 (es) Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento.
FR2802417B1 (fr) Preparations cosmetiques et/ou pharmaceutiques contenant au moins un extrait de brassicaceae
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
ATE83379T1 (de) Coccidiozide mittel.
FR2804601B1 (fr) Dispositif d'application de principes actifs utilisables dans le domaine pharmaceutique ou cosmetique
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2128353T3 (es) Composicion topica que contiene penciclovir.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559682

Country of ref document: ES